ea0049ep35 | Adrenal cortex (to include Cushing's) | ECE2017
Mongioi Laura Maria
, Condorelli Rosita Angela
, Cimino Laura
, La Vignera Sandro
, Calogero Aldo Eugenio
Introduction: Treatment of adrenal insufficiency (AI) in the last years has been object of important changes due to the development of a dual-release preparation of hydrocortisone (Plenadren®). Hydrocortisone dual-release therapy contemplates a once-daily tablet that allows more closely mimicking the physiological circadian rhythm cortisol, thus avoiding overexposure.Objective: The aim of the study was to value effects of Plenadren administration on...